US BANCORP \DE\ - INHIBRX INC ownership

INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 103 filers reported holding INHIBRX INC in Q3 2022. The put-call ratio across all filers is 34.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of INHIBRX INC
ValueSharesWeighting
Q3 2023$3,542
+110.0%
193
+196.9%
0.00%
Q2 2023$1,687
-15.6%
65
-47.2%
0.00%
Q3 2022$2,0000.0%123
-13.4%
0.00%
Q2 2022$2,000
+100.0%
142
+1083.3%
0.00%
Q4 2021$1,000120.00%
Other shareholders
INHIBRX INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,023,325$11,615,0003.23%
Opaleye Management Inc. 590,000$6,697,0003.02%
Sio Capital Management, LLC 365,210$4,145,0001.56%
Perceptive Advisors 1,914,592$21,731,0000.68%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 794,682$9,020,0000.65%
Birchview Capital, LP 70,448$800,0000.58%
Meridian Wealth Advisors, LLC 122,315$1,388,0000.37%
VIKING GLOBAL INVESTORS LP 5,305,866$60,222,0000.28%
ArrowMark Colorado Holdings LLC 1,412,236$16,029,0000.18%
Alaethes Wealth LLC 19,341$220,0000.16%
View complete list of INHIBRX INC shareholders